As no studies were available to support the use of gemcitabine as single agent neither in first or second line, the CHMP requested the MAH to further discuss the indication of Gemzar in ovarian cancer. Nu sunt selectate sau validate manual, așadar pot conține termeni inadecvați. Te rugăm să raportezi exemplele pe care le consideri inadecvate.